93532/ouro-botics-bioprinting
AMS X

Ouro_botics Developing Modular Bioprinting Platform for Students, Biohackers and Researchers

Formnext
RAPID

Share this Article

454bbcaba03310aa5b1a69e0a3d4d186The founder of Ouro_botics, Jemma Redmond, was working on her masters thesis about four years ago – a tome entitled An Investigation into Osteoblast Adhesion — when she discovered bioprinting. In Dublin, around her kitchen table, her company came to fruition.cdeffecc5ff13ff7035e4b0bc9dcb352

“One particular application was cell adhesion, and so I set out to create some ECMS (extra cellular matrices, or scaffolds) and grow some osteoblasts (bone) on the scaffolds,” she says. “Having a limited budget, I went off and bought a number of 3D printers and started modifying them into 3D bioprinters. However, I was subsequently told that my budget had been cut rather significantly by the university where I was studying. Being not a very happy bunny I decided to print some fingers for my scaffolds.”

As she began to realize that a bioprinter could open up interesting possibilities and applications, she says that sold her own businesses and started building her own printers testing out different configurations and methods, and Ouro_botics was formed to build an affordable, modular bioprinting platform for students, biohackers and researchers.

“After months of hard work,” Redmond says of Ouro_botics, “we built a 10 micron accuracy bioprinting platform that can be fitted with different types of extruder heads and allows researcher to try out different biomaterials such as gelatine, alginate, chitosan, keratin with different extrusion methods.”

She says the bioprinting is more than a single technique with one material and one application; it’s many techniques, many applications and many materials. The key is to have a machine that can be readily adapted. To build the proper system, she and her team printed simple copies of finger bones with cells, reproductive systems and carcinomas with simple materials and through that process, they learned what would be required of a hardware solution.microbiology and textiles

As for what the company is focusing on now, Redmond says “augmented tissue” is a point of interest.

“Why make a copy of the same thing, the same organ, when you can literally, make it better? Stronger, more efficient, longer lasting, perhaps with embedded sensors to give you an idea of whats going on inside your body,” Redmond says of the concept. “It sounds like science fiction, but it is certainly doable. And biomimicry is a subject as a scientist that interests me greatly. We can solve a lot of engineering problems by looking to what we can find in nature. And thus we can perhaps do the same with our own bodies.”

According to Redmond, the future holds the promise of human tissue arrays which will be used for drug testing, and those constructs will result in cheaper, better drugs to treat all manner of ailments. 941892974d3a5e10736874968222b251

“With lab grown human tissue for testing, we can reduce and eventually eliminate the need for animal testing,” she says.

But she adds that she’s convinced the major issue facing development in bioprinting isn’t so much the efficacy of the technologies themselves,but rather the pace of regulatory approvals.

Redmond says that Ouro_botics is an alumni outgrowth of the Haxlr8r accelerator in Shenzhen, China, and part of the SOSVentures Group headed by entrepreneur Sean O’Sullivan. Working alongside Dr. Tony Herbert, the Financial Director of Ouro_botics, the company is busy navigating the entrepreneurial climate in China.

Hebert has a background in Plasma Physics and engineering, and he’s also currently the CEO of Irish Precision Optics, a manufacturer of optical components for customers such as the European Space Agency.

What do you think about upstart bioprinting concerns like Jemma Redmond’s Ouro_botics? Let us know in the Ouro_botics forum thread on 3DPB.com.

www.ouro-botics.com_explains_Bioprinting_oxljjr

 



Share this Article


Recent News

3D Printing News Briefs, November 19, 2026: Formnext, Formnext, Formnext!

Siemens is the Most Logical Company to Lead the AI for AM Market



Categories

3D Design

3D Printed Art

3D Printed Food

3D Printed Guns


You May Also Like

Formnext 2026 Day Two: Release Me

You always hear such negative things about Haiti, but it’s nice to see some good news come out, what with them getting their own LPBF machines. There is still optimism...

The AM Industry Is Growing. Arno Held Thinks It Still Needs to Get Smaller

Additive manufacturing is now a $24.2 billion industry, but Arno Held believes too many companies still compete for market share. That was one of the more pointed arguments during an...

3DPOD 322: Neil Hopkinson on Stratasys’ New H550 SAF 3D Printer

Coming to you from Formnext 2026, Joris Peels and Maxwell Bogue welcome Neil Hopkinson, Vice President of SAF Technology at Stratasys, for a conversation about what’s next in industrial 3D...

Formnext 2026: Large-Format 3D Printing Gets Bigger, Smarter, and More Production-Ready

The race to build bigger 3D printers is picking up speed at Formnext 2026, as manufacturers turn their attention to industrial-scale production. At the trade show in Frankfurt, Germany, companies...